SkinHealth Systems (SKIN) Capital Expenditures (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Capital Expenditures data on file, last reported at $224000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 397.78% year-over-year to $224000.0 in Q1 2026; TTM through Mar 2026 was $482000.0, a 5.47% increase from a year earlier, with the FY2025 full-year figure at $303000.0, down 59.92% from the prior year.
• Capital Expenditures for Q1 2026 stood at $224000.0, up from $139000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for SKIN reached as high as $4.3 million in Q3 2022 and fell as low as $4000.0 in Q3 2024.
• Historically, Capital Expenditures has averaged $938529.4 across 5 years, with a median of $224000.0 in 2026.
• Across the five-year window, Capital Expenditures sank 97.7% in 2024 and jumped 575.0% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $967000.0 in 2022, then plunged by 97.1% to $28000.0 in 2023, then jumped by 164.29% to $74000.0 in 2024, then soared by 87.84% to $139000.0 in 2025, then soared by 61.15% to $224000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $224000.0 in Q1 2026, $139000.0 in Q4 2025, and $27000.0 in Q3 2025.